American Journal of Psychiatry最新文献

筛选
英文 中文
Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek. 老年人受吸食大麻影响的风险更高:对瓦拉塞克的回应
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 DOI: 10.1176/appi.ajp.20240681
Lewei Allison Lin
{"title":"Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek.","authors":"Lewei Allison Lin","doi":"10.1176/appi.ajp.20240681","DOIUrl":"https://doi.org/10.1176/appi.ajp.20240681","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142556946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use? 神经黑素敏感核磁共振成像(MRI)能否深入揭示导致药物使用的多巴胺能通路?
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 DOI: 10.1176/appi.ajp.20240853
Finnegan J Calabro, Ashley C Parr
{"title":"Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?","authors":"Finnegan J Calabro, Ashley C Parr","doi":"10.1176/appi.ajp.20240853","DOIUrl":"https://doi.org/10.1176/appi.ajp.20240853","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142556942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disparities in Treatment for Alcohol Use Disorder Among All of Us Participants. 我们所有人参与者在酒精使用障碍治疗方面的差异。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 DOI: 10.1176/appi.ajp.20230730
Phuc Le, Jacob James Rich, Eden Y Bernstein, Joseph Glass, Hamlet Gasoyan, Sudie E Back, Thanh C Bui, Gina Ayers, Michael B Rothberg
{"title":"Disparities in Treatment for Alcohol Use Disorder Among All of Us Participants.","authors":"Phuc Le, Jacob James Rich, Eden Y Bernstein, Joseph Glass, Hamlet Gasoyan, Sudie E Back, Thanh C Bui, Gina Ayers, Michael B Rothberg","doi":"10.1176/appi.ajp.20230730","DOIUrl":"10.1176/appi.ajp.20230730","url":null,"abstract":"<p><strong>Objective: </strong>The authors examined racial/ethnic and socioeconomic disparities in receiving treatment for alcohol use disorder (AUD).</p><p><strong>Methods: </strong>A retrospective cohort study was conducted that included adults (≥18 years) with AUD from the All of Us Controlled Tier database v7. Outcomes were lifetime receipt of FDA-approved medications (disulfiram, acamprosate, and naltrexone), psychotherapy (individual, family, and group-based session), and combination treatment (medication and psychotherapy). The study examined treatment receipt by race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, other), insurance (private, Medicare, Medicare and Medicaid, Medicaid, Veteran Affairs [VA], none), income (<$10K, $10-<$50K, $50-$100K, >$100K), and area deprivation index (ADI) quintiles. Multivariable logistic and multinomial logistic regressions were used to assess the association between patient characteristics and treatment receipt.</p><p><strong>Results: </strong>The cohort consisted of 18,692 patients (mean age=57.1 years; 60.7% were male; 47.1% were non-Hispanic White). Almost 70% received no treatment, 11.4% received medication, 24.0% received psychotherapy, and 4.9% received combination treatment. In adjusted analysis, non-Hispanic Black (aOR=0.78, 95% CI=0.69-0.89) and Hispanic (aOR=0.75, 95% CI=0.64-0.88) individuals were less likely to receive medication than non-Hispanic White counterparts. There was no association between race/ethnicity and receipt of psychotherapy or combination treatment. Compared with private insurance, dual eligibility was associated with less use of medication, Medicare and Medicaid with less use of medication and combination treatment, and VA and no insurance with more use of psychotherapy and combination treatment. Higher income and lower ADI were positively associated with all treatment types.</p><p><strong>Conclusions: </strong>There are disparities in AUD treatment by race/ethnicity, socioeconomic status, and insurance. Systematic approaches are required to improve equitable access to effective treatment.</p>","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142556943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use. 使用 DSM-5 与 DSM-IV 标准对美国非老年成人药物使用障碍的 12 个月患病率进行估计。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 DOI: 10.1176/appi.ajp.20231060
Wilson M Compton, Emily B Einstein, Beth Han
{"title":"12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use.","authors":"Wilson M Compton, Emily B Einstein, Beth Han","doi":"10.1176/appi.ajp.20231060","DOIUrl":"https://doi.org/10.1176/appi.ajp.20231060","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142556940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Cannabis Use Reduction With Improved Functional Outcomes: An Exploratory Aggregated Analysis From Seven Cannabis Use Disorder Treatment Trials to Extract Data-Driven Cannabis Reduction Metrics. 减少吸食大麻与改善功能结果的关系:从七项大麻使用障碍治疗试验中提取数据驱动的大麻减量指标的探索性汇总分析。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 Epub Date: 2024-10-09 DOI: 10.1176/appi.ajp.20230508
Erin A McClure, Brian Neelon, Rachel L Tomko, Kevin M Gray, Aimee L McRae-Clark, Nathaniel L Baker
{"title":"Association of Cannabis Use Reduction With Improved Functional Outcomes: An Exploratory Aggregated Analysis From Seven Cannabis Use Disorder Treatment Trials to Extract Data-Driven Cannabis Reduction Metrics.","authors":"Erin A McClure, Brian Neelon, Rachel L Tomko, Kevin M Gray, Aimee L McRae-Clark, Nathaniel L Baker","doi":"10.1176/appi.ajp.20230508","DOIUrl":"10.1176/appi.ajp.20230508","url":null,"abstract":"<p><strong>Objective: </strong>This exploratory analysis sought to determine whether decreases in cannabis use are associated with improvements in cannabis-related problems and functional outcomes, and if so, what percentage decrease is associated with improvement.</p><p><strong>Methods: </strong>Data were aggregated from seven cannabis use disorder treatment trials conducted in the United States (N=920; ages 13 years and older; mean age, 25 years; 30% female, 7% Black, 11% Hispanic/Latinx). Outcome measures included the patient-reported Marijuana Problems Scale (MPS), Health-Related Quality of Life scale (HRQOL), and Pittsburgh Sleep Quality Index and the clinician-rated Clinical Global Impressions (CGI) severity and improvement scales (CGI-S and CGI-I). Generalized estimating equations tested the association between changes in 4-week cannabis use and improvements in functional outcomes. Classification and regression tree (CART) models were developed to determine what reductions in cannabis use could be used as classifiers of improvement.</p><p><strong>Results: </strong>Decreases in the amount and frequency of cannabis use were significantly associated with improvements in MPS severity and total scores as well as improvements on the CGI-I and in sleep quality, but not improvements on the HRQOL. CART models performed best for CGI-I scores (72%-75% correct classification), while other outcome measures did not perform as well (40%-62% correct classification). CART models showed improvements on the CGI at 74% reduction in use amounts and 47% reduction in use days.</p><p><strong>Conclusions: </strong>Reductions in cannabis use (∼50% reduction in use days and ∼75% reduction in use amounts) were associated with clinician-assessed improvement, which suggests that cannabis use reduction may yield benefit among individuals with cannabis use disorder. These exploratory results extract a data-driven metric to inform future studies, clinicians, patients, and policy recommendations.</p>","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing Disparities in Alcohol Use Disorder Treatment: A Call to Action. 解决酒精使用障碍治疗中的差异:行动呼吁书》。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 DOI: 10.1176/appi.ajp.20240861
Henry R Kranzler, Rachel Vickers-Smith
{"title":"Addressing Disparities in Alcohol Use Disorder Treatment: A Call to Action.","authors":"Henry R Kranzler, Rachel Vickers-Smith","doi":"10.1176/appi.ajp.20240861","DOIUrl":"https://doi.org/10.1176/appi.ajp.20240861","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142556941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Neuromelanin-Sensitive MRI Signal With Lifetime Substance Use in Young Women. 年轻女性神经黑素敏感核磁共振成像信号与终生使用药物的关系
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 Epub Date: 2024-10-09 DOI: 10.1176/appi.ajp.20220819
Greg Perlman, Kenneth Wengler, Scott J Moeller, Roman Kotov, Daniel N Klein, Jodi J Weinstein, Guillermo Horga, Anissa Abi-Dargham
{"title":"Association of Neuromelanin-Sensitive MRI Signal With Lifetime Substance Use in Young Women.","authors":"Greg Perlman, Kenneth Wengler, Scott J Moeller, Roman Kotov, Daniel N Klein, Jodi J Weinstein, Guillermo Horga, Anissa Abi-Dargham","doi":"10.1176/appi.ajp.20220819","DOIUrl":"10.1176/appi.ajp.20220819","url":null,"abstract":"<p><strong>Objective: </strong>Midbrain dopamine function plays a key role in translational models of substance use disorders. Whether midbrain dopamine function is associated with substance use frequency and severity or reward function in 20-24 year-olds remains a critical gap in knowledge. The authors collected neuromelanin-sensitive magnetic resonance imaging (NM-MRI), a validated index of lifetime dopamine function in the substantia nigra/ventral tegmentum area (SN-VTA) complex, to characterize altered dopamine function.</p><p><strong>Method: </strong>Midbrain NM-MRI contrast-to-noise ratio (CNR) was acquired in 135 20-24 year-olds (105 women and 30 men). A composite measure of cumulative substance use was derived from factor analysis of lifetime alcohol intoxications, lifetime cannabis use, use of nicotine in heaviest month, number of classes of drugs used, and ever meeting DSM-5 criteria for a SUD. Trait reward function was assessed by self-report.</p><p><strong>Results: </strong>Cumulative substance use was significantly positively associated with NM-MRI CNR in a large area of the bilateral SN-VTA complex, an effect which was driven by women (who comprised most of the sample) and by voxels with greater NM-MRI CNR, including the ventral tegmentum area. NM-MRI CNR was not associated with individual differences in trait reward function.</p><p><strong>Conclusions: </strong>History of substance use is associated with greater NM signal in NM-rich areas of the midbrain, especially in women. Future longitudinal studies with repeated NM-MRI assessments, especially in younger cohorts and while including more men, are warranted to evaluate whether aberrant dopamine function predates, follows, or is modulated by substance use.</p>","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substance Use Disorders. 药物使用障碍。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 DOI: 10.1176/appi.ajp.20240888
Ned H Kalin
{"title":"Substance Use Disorders.","authors":"Ned H Kalin","doi":"10.1176/appi.ajp.20240888","DOIUrl":"https://doi.org/10.1176/appi.ajp.20240888","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142556948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Higher Prevalence Estimates of Substance Use Disorders With DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use: The Role of DSM-IV Diagnostic Orphans. 使用 DSM-5 与 DSM-IV 标准的美国非老年成人物质使用障碍患病率估计值更高:DSM-IV 诊断孤儿的作用。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 DOI: 10.1176/appi.ajp.20240852
Deborah Hasin, Malka Stohl
{"title":"Higher Prevalence Estimates of Substance Use Disorders With DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use: The Role of DSM-IV Diagnostic Orphans.","authors":"Deborah Hasin, Malka Stohl","doi":"10.1176/appi.ajp.20240852","DOIUrl":"https://doi.org/10.1176/appi.ajp.20240852","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142556944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Older Adults are at Heightened Risk of the Effects of Cannabis Use. 老年人受吸食大麻影响的风险更高。
IF 15.1 1区 医学
American Journal of Psychiatry Pub Date : 2024-11-01 DOI: 10.1176/appi.ajp.20240113
Art Walaszek
{"title":"Older Adults are at Heightened Risk of the Effects of Cannabis Use.","authors":"Art Walaszek","doi":"10.1176/appi.ajp.20240113","DOIUrl":"https://doi.org/10.1176/appi.ajp.20240113","url":null,"abstract":"","PeriodicalId":7656,"journal":{"name":"American Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":15.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142556945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信